NHU(SZ:002001)2025-04-14 11:25Financial Performance - The company expects a net profit attributable to shareholders of 1.8 billion to 1.9 billion CNY for Q1 2025, representing a year-on-year increase of 107% to 118% compared to 869.62 million CNY in the same period last year [3]. - The net profit after deducting non-recurring gains and losses is also projected to be between 1.8 billion to 1.9 billion CNY, reflecting a growth of 110% to 122% from 857.47 million CNY in the previous year [3]. - Basic earnings per share are anticipated to be between 0.59 CNY and 0.62 CNY, up from 0.28 CNY per share in the same quarter last year [3]. Business Strategy - The increase in performance is attributed to higher sales volume and prices of key products in the nutrition segment compared to the previous year [5]. - The company will continue to focus on integrated, series, and collaborative development strategies, emphasizing "Chemical +" and "Biological +" main strategies [5]. - Future plans include enhancing application research and service capabilities, with a focus on nutrition products, flavors, high polymer new materials, and raw pharmaceutical materials [5]. - The company aims to strengthen its global marketing network and promote sustainable high-quality development while exploring opportunities in strategic emerging industries such as plant protection, new energy, energy conservation, and environmental protection [6]. Investment Risks - The financial data in the earnings forecast has not been audited by registered accountants, and investors are advised to pay attention to investment risks [4][7].